Royal Gold Q1 2026: Deleveraging on Track but Valuation Leaves No Room for Error

What happened

Royal Gold's Q1 2026 results showed continued revenue growth on high gold prices and incremental volumes from recent acquisitions, but the narrative remains dominated by balance-sheet repair after the 2025 acquisition binge. The company reduced revolver debt further, consistent with its guided mid-2027 deleveraging target, though the pace may slow as Hod Maden capital calls ramp. Kansanshi stream deliveries appear in line with revised expectations, but the key risk—Hod Maden's 30% working interest—remains unhedged and could absorb significant cash before first production in 2028. While the market cheered the debt paydown and strong margins, the stock at ~40x earnings already prices in flawless execution on integration, project delivery, and sustained high gold prices. Any deviation from the bull case—whether from gold normalization, cost overruns, or slower deleveraging—would compress the multiple towards the low-$200s.

Implication

The company's strategy depends on uninterrupted gold strength and flawless execution; monitor quarterly debt levels, Hod Maden capex, and Kansanshi deliveries for early warning signs.

Thesis delta

The Q1 call confirmed steady deleveraging progress, but the fundamental risk asymmetry between a premium multiple and new operational/complexity risks has not narrowed. The investment thesis shifts from 'potential sell' to 'confirming sell' as execution checks pass, but valuation leaves no margin of safety; we maintain a cautious stance and recommend trimming on strength.